S&N’s BlueSky Purchase Puts Negative Pressure On Kinetic Concepts
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew's entry into the rapidly growing, $1.2 billion market for negative pressure wound therapy via the purchase of BlueSky Medical likely will intensify competition in the treatment category
You may also be interested in...
Key KCI Patents For Negative Pressure Wound Therapy Ruled Invalid
Smith & Nephew met a major legal test Oct. 18 in its quest to challenge Kinetic Concepts Inc.’s dominance in the negative pressure wound therapy space.
Key KCI Patents For Negative Pressure Wound Therapy Ruled Invalid
Smith & Nephew met a major legal test Oct. 18 in its quest to challenge Kinetic Concepts Inc.’s dominance in the negative pressure wound therapy space.
Negative pressure patents
The U.S. Patent and Trademark Office preliminarily has labeled as "unpatentable" three of Kinetic Concepts' negative pressure wound therapy patents in a re-examination requested by competitor Smith & Nephew, according to Smith & Nephew. KCI now has the opportunity to respond to the decision within two months before the Patent Office makes a final decision. Smith & Nephew acquired negative pressure wound therapy firm BlueSky in 2007 (1"The Gray Sheet" May 14, 2007, p. 16)